Drug intelligence / Profile preview

Pregvit

Development stage
Unknown
Lead developer
Duchesnay
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Pregvit is a prescription-only prenatal multivitamin and mineral supplement developed by Duchesnay. It is uniquely formulated as a two-tablet daily regimen, consisting of a pink morning tablet and a blue evening tablet, to optimize the absorption of its various components. The morning tablet contains iron and folic acid, while the evening tablet contains calcium; this separation is specifically designed to prevent calcium from inhibiting the gastrointestinal absorption of iron. Pregvit is indicated for use in women planning pregnancy, during pregnancy, and in the postpartum period to ensure adequate intake of essential nutrients, including 1.1 mg of folic acid to reduce the risk of neural tube defects.

Brand names
Pregvit
Other names
PregVit
02

Targets

FOLR1 (FRα)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Pregvit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pregvit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call